Abrdn PLC Catalent, Inc. Transaction History

Abrdn PLC

$53.3 Billion
Q3 2024

A detailed history of Abrdn PLC transactions in Catalent, Inc. stock. As of the latest transaction made, Abrdn PLC holds 70,559 shares of CTLT stock, worth $4.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

70,559

Previous 71,205 0.91%

Holding current value

$4.17 Million

Previous $4 Million 6.74%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$56.16 - $60.96 $36,279 - $39,380	-646 Reduced 0.91%	70,559 $4.27 Million
Q2 2024 Aug 09, 2024	SELL	$53.58 - $57.02 $221,017 - $235,207	-4,125 Reduced 5.48%	71,205 $4 Million
Q1 2024 May 08, 2024	SELL	$42.56 - $59.82 $4.98 Million - $7.01 Million	-117,113 Reduced 60.86%	75,330 $4.25 Million
Q4 2023 Jan 31, 2024	BUY	$32.18 - $46.57 $4.78 Million - $6.92 Million	148,522 Added 338.16%	192,443 $8.65 Million
Q3 2023 Nov 06, 2023	SELL	$44.2 - $50.2 $50,343 - $57,177	-1,139 Reduced 2.53%	43,921 $2 Million
Q2 2023 Jun 20, 2024	SELL	$31.86 - $67.26 $16,694 - $35,244	-524 Reduced 1.15%	45,060 $1.95 Million
Q2 2023 Aug 04, 2023	SELL	$31.86 - $67.26 $16,694 - $35,244	-524 Reduced 1.15%	45,060 $1.95 Million
Q1 2023 Jun 20, 2024	BUY	$45.44 - $74.26 $5,316 - $8,688	117 Added 0.26%	45,584 $3 Million
Q1 2023 Apr 28, 2023	BUY	$45.44 - $74.26 $5,316 - $8,688	117 Added 0.26%	45,584 $3 Million
Q4 2022 Jun 20, 2024	SELL	$41.39 - $81.0 $1.24 Million - $2.42 Million	-29,863 Reduced 39.64%	45,467 $2.05 Million
Q4 2022 Feb 09, 2023	BUY	$41.39 - $81.0 $84,187 - $164,754	2,034 Added 4.68%	45,467 $2.05 Million
Q3 2022 Nov 10, 2022	BUY	$72.36 - $113.1 $8,610 - $13,458	119 Added 0.27%	43,433 $3.14 Million
Q2 2022 Aug 05, 2022	SELL	$87.2 - $114.05 $21,276 - $27,828	-244 Reduced 0.56%	43,314 $4.64 Million
Q1 2022 May 04, 2022	SELL	$94.19 - $124.49 $772,452 - $1.02 Million	-8,201 Reduced 15.84%	43,558 $4.92 Million
Q4 2021 Feb 08, 2022	SELL	$119.57 - $139.07 $562,337 - $654,046	-4,703 Reduced 8.33%	51,759 $6.63 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $349,234 - $455,377	-3,199 Reduced 5.36%	56,462 $7.57 Million
Q2 2021 Aug 10, 2021	SELL	$100.34 - $115.69 $93,416 - $107,707	-931 Reduced 1.54%	59,661 $6.45 Million
Q1 2021 May 06, 2021	BUY	$101.51 - $125.27 $1.5 Million - $1.85 Million	14,776 Added 32.25%	60,592 $6.38 Million
Q4 2020 Feb 10, 2021	BUY	$85.88 - $105.36 $378,730 - $464,637	4,410 Added 10.65%	45,816 $4.77 Million
Q3 2020 Oct 21, 2020	BUY	$72.74 - $92.5 $2.35 Million - $2.99 Million	32,327 Added 356.06%	41,406 $3.55 Million
Q2 2020 Aug 10, 2020	BUY	$48.02 - $79.04 $435,973 - $717,604	9,079 New	9,079 $665,000

Others Institutions Holding CTLT

# of Institutions

512

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account